Skip to main content
Quest Diagnostics

Oddball NPS: Prevalence and Trends in Clinical Specimens

SOFT 2025

Society for Forensic Toxicologists

Portland, OR, Oct 26-31, 2025

Oral presentation: Oddball NPS: Prevalence and Trends in Clinical Specimens

Authors: Neifeld J

Medical Specialty: Prescription Drug Monitoring, Toxicology

Related content

On-Demand Webinar
The Growing Crisis of Novel Psychoactive Substances
Audio Podcast
Novel Psychoactive Substances (NPS): A Dangerous, Widespread Public Health Issue
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing
Audio Podcast
Why and When to Use Oral Fluid Testing
Conference Presentation
The Emergence of the Designer Stimulants Fluorexetamine and 2-fluoro-2oxo-PCE in Clinical Urine Specimens
Test FAQ
Drug Testing General Toxicology Blood or Serum
Audio Podcast
Drug Testing for Stimulants

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.